High Incidence of Psychiatric Disorders Associated with Cycloserine Treatment of Multidrug-Resistant Tuberculosis Patients: A Cohort Study in Beijing, China

OBJECTIVE: Cycloserine (CS) is a group B anti-tuberculosis (TB) drug endorsed by the World Health Organization (WHO) for the treatment of drug-resistant (DR)-TB. Despite CS widespread acceptance and known efficacy, the high potential of drug-associated psychiatric disorders is a major concern to mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Yu, Liu, Rongmei, Song, Yanhua, Lv, Zizheng, Gao, Mengqiu, Nie, Lihui, Ge, Qiping, Wu, Xiaoguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289756/
https://www.ncbi.nlm.nih.gov/pubmed/35859910
http://dx.doi.org/10.2147/IDR.S369715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289756/
https://www.ncbi.nlm.nih.gov/pubmed/35859910
http://dx.doi.org/10.2147/IDR.S369715

Ejemplares similares